Company Overview of Tempero Pharmaceuticals, Inc.
Tempero Pharmaceuticals, Inc. develops medicines for the treatment of autoimmune diseases. It develops therapies that selectively prevent Th17-driven diseases, or enhance the development of specialized Treg subsets. Its products treat autoimmune disorders, such as multiple sclerosis, inflammatory bowel disease, psoriasis, and type 1 diabetes. The company was founded in 2009 and is based in Cambridge, Massachusetts. Tempero Pharmaceuticals, Inc. operates as a subsidiary of GlaxoSmithKline plc.
200 Technology Square
Cambridge, MA 02139
Founded in 2009
Key Executives for Tempero Pharmaceuticals, Inc.
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3D Bio Holdings LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
To contact Tempero Pharmaceuticals, Inc., please visit www.temperopharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.